跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 319 条关于
“HK2”
全部
319
临床试验
173
药物
74
机构
33
资讯
39
11个月前
Vidac Pharma Secures Broad U.S. Patent Protection for Novel Mitochondria-Targeted Cancer Therapy
8个月前
Vidac Pharma Secures USPTO Patent for Novel Hexokinase 2-Mitochondrial Interaction Modulators
去年
Vidac Pharma Secures Funding for Clinical Trials of Cancer Drug Candidates
去年
Glycolytic Reprogramming Emerges as Key Therapeutic Target in Gastric Cancer
11个月前
Vidac Pharma to Explore Potential Collaboration with Johnson & Johnson in Intratumoral Oncology
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
7个月前
HKU Researchers Demonstrate Finerenone's Potential in Treating Premature Ovarian Insufficiency
去年
HKU Researchers Discover Atorvastatin's Potential as Novel Liver Cancer Treatment
去年
HKU Researchers Develop Breakthrough Needle-Free Flu Vaccine with Broader Protection
去年
Roche Adjusts Tominersen Dosing in GENERATION HD2 Trial for Huntington's Disease
第 1 页,共 4 页
上一页
下一页